(1)
Song, X. Targeting of Both PI3K Akt MTOR Pathway and Mutant EGFR to Overcome Resistance to Tyrosine Kinase Inhibitors in Mutant EGFR-Mediated Lung Cancer. OR 2013, 1 (1), pp.13-19. https://doi.org/10.14259/or.v1i1.81.